C&R Research, a South Korean contract research organisation (CRO), is expanding its clinical trial operations in Indonesia as part of its broader ASEAN growth strategy.

• Regional Hub: The company coordinates its global clinical development activities through its Singapore entity, C&R Healthcare Global, which was established in 2017.
• Medical Focus: In Indonesia, C&R Research is building capabilities in chronic disease areas, with a particular focus on type 2 diabetes and metabolic conditions.
• Digital Strategy: The firm is advancing its “Data CRO” approach by deploying an integrated AI- and data-driven platform to manage clinical trials more efficiently.
• Strategic Positioning: The initiative supports C&R’s goal of strengthening its presence as a regional clinical research hub in Southeast Asia.

This summary is based on a press release issued by C&R Research.